| Study of the Effects of ITCA 650 on Gastric Emptying and Interaction of ITCA 650 on 4 Commonly Studied Drugs (NCT02641899) | Intarcia Therapeutics | 2015-12-01 |
| A Research Study To Test How Filgrastim Hospira Works In The Body Of Healthy Study Subjects When Given By Subcutaneous Injection (Shot) Compared To An Already U.S.-Approved Drug Neupogen® (Amgen) (NCT02766647) | Pfizer | 2015-12-01 |
| SAD and MAD Study to Evaluate Safety, Tolerability, and Pharmacokinetics (PK) of TD-1473 in Healthy Subjects (NCT02657122) | Theravance Biopharma | 2015-12-01 |
| Evaluating Muscle Weakness Improvement With Lorcaserin in ICU (NCT02523690) | Johns Hopkins University | 2015-12-01 |
| Open Label, Drug-Drug Interaction (DDI) Study of Dupilumab (REGN668/SAR231893) in Patients With Moderate to Severe Atopic Dermatitis (AD) (NCT02647086) | Regeneron Pharmaceuticals | 2015-12-01 |
| BATS With in Combination With Low Dose IL-1 and GM-CSF for Advanced Pancreatic Cancer (NCT02620865) | Barbara Ann Karmanos Cancer Institute | 2015-12-01 |
| Safety and Efficacy of Adipose Derived Stem Cells in Refractory Rheumatoid Arthritis, Systemic Lupus Erythematosus or Sharp's Syndrome (NCT02741362) | Arkansas Heart Hospital | 2015-12-01 |
| Phase I Clinical Study Combining L19-IL2 With SABR in Patients With Oligometastatic Solid Tumor (NCT02086721) | Maastricht Radiation Oncology | 2015-12-01 |
| Dasatinib in Combination With Chemotherapy for Relapsed or Refractory Core Binding Factor Acute Myeloid Leukemia (NCT02680951) | Emory University | 2015-12-01 |
| Safety, Tolerability and the Effects on Cerebrospinal Fluid Spectrin Breakdown Product-145 Levels of ABT-957 in Subjects With Mild Alzheimer's Disease and Mild Cognitive Impairment (NCT02573740) | AbbVie | 2015-12-01 |
| Phase Ib Study to Determine MTD of AZD1775 Monotherapy in Patients With Locally Advanced or Metastatic Solid Tumours. (NCT02610075) | AstraZeneca | 2015-12-01 |
| Study of Trametinib and Nab-paclitaxel in Patients With Melanoma (NCT02300935) | SCRI Development Innovations, LLC | 2015-12-01 |
| A Study of the PK Interaction of CXA-10 With Pravastatin and Vytorin® in Healthy Males (NCT02547402) | Complexa, Inc. | 2015-12-01 |
| Study of PD1 Blockade by Pembrolizumab With Stereotactic Body Radiotherapy in Advanced Solid Tumors (NCT02608385) | University of Chicago | 2015-12-01 |
| PPI And Food Effect Study For PF-06463922 In Healthy Volunteers (NCT02569554) | Pfizer | 2015-12-01 |
| A Comparative Trial Focusing on Injections With the Medical Device DV3316 Pen-injector Versus FlexPen® (NCT02627287) | Novo Nordisk A/S | 2015-12-01 |
| Study of the Effect of ITCA 650 on the PK/PD of Oral Contraceptive in Healthy Female Subjects (NCT02641990) | Intarcia Therapeutics | 2015-12-01 |
| To Assess Bioequivalence of Loratadine Oral Solution/Syrup Versus Claritin Peach Syrup (NCT02593747) | Bayer | 2015-12-01 |
| Tolerability, Safety and Pharmacokinetic Study Of Mianhuahua Flavonoids Tablets in Healthy Adult Subjects (NCT02622230) | Xinjiang Uygur Pharmaceutical Co., Ltd. | 2015-12-01 |
| Study to Explore Drug-drug Interactions Between DWC20155 and DWC20156 in Healthy Subjects (NCT02704559) | Daewoong Pharmaceutical Co. LTD. | 2015-12-01 |
| A Single Ascending Dose Study in Healthy Participants and Multiple Dose Study of JNJ-55920839 in Participants With Mild to Moderate Systemic Lupus Erythematosus (NCT02609789) | Janssen Research & Development, LLC | 2015-12-01 |
| A Phase 1 Study to Investigate the Safety, Tolerance, Food Effect, Pharmacokinetics and Pharmacodynamics of Single and Multiple Doses of Extended Release Formulations of Centanafadine (CTN) in Young Healthy Subjects (NCT02827513) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2015-12-01 |
| Prostate Embolization for Massive Benign Prostatic Hypertrophy (BPH) (NCT02676544) | Rhode Island Hospital | 2015-12-01 |
| Phase I/II Trial of Everolimus in Combination With Lonafarnib in Progeria (NCT02579044) | Boston Children's Hospital | 2015-12-01 |
| Safety and Immunogenicity in Age De-Escalation of PfSPZ Vaccine in Tanzanian Adults, Children, and Infants (NCT02613520) | Sanaria Inc. | 2015-12-01 |
| The Clinical Safety of Alcoholic Extract Sahastara Remedy of Extract Capsule in Healthy Volunteers (NCT02568059) | Thammasat University | 2015-12-01 |
| Trial of Tolcapone With Oxaliplatin for Neuroblastoma (NCT02630043) | Giselle Sholler | 2015-12-01 |
| Study to Evaluate Sotagliflozin in Subjects With Varying Degrees of Renal Function (NCT02647918) | Lexicon Pharmaceuticals | 2015-12-01 |
| Adhesion of Lidocaine Topical System 1.8% (NCT04312750) | Scilex Pharmaceuticals, Inc. | 2015-12-01 |
| Parvovirus H-1 (ParvOryx) in Patients With Metastatic Inoperable Pancreatic Cancer (NCT02653313) | Oryx GmbH & Co. KG | 2015-12-01 |
| Effect of GDC-0810 on the Pharmacokinetics of Pravastatin in Healthy Female Subjects of Non-Childbearing Potential (NCT02621957) | Genentech, Inc. | 2015-12-01 |
| Tolerability to HS-20004 With Titration Administration in Type 2 Diabetic Patients (NCT02750007) | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 2015-12-01 |
| 6,8-Bis(Benzylthio)Octanoic Acid, Cytarabine, and Daunorubicin Hydrochloride in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia (NCT02472626) | Wake Forest University Health Sciences | 2015-12-01 |
| A Clinical Trial to Evaluate the Effects of Food on the Bioavailability of CKD-397 in Healthy Male Subjects (NCT02615782) | Chong Kun Dang Pharmaceutical | 2015-12-01 |
| Interferon-α After DLI for the Prevention of Relapse (NCT02568241) | Peking University People's Hospital | 2015-12-01 |
| Study of Itacitinib in Combination With Corticosteroids for the Treatment of Acute GVHD (NCT02614612) | Incyte Corporation | 2015-12-01 |
| Study of COTI-2 as Monotherapy or Combination Therapy for the Treatment of Malignancies (NCT02433626) | Critical Outcome Technologies Inc. | 2015-12-01 |
| Pilot Study to Assess Safety, Preliminary Efficacy and Pharmacokinetics of S.C. Pegcetacoplan (APL-2) in PNH Subjects. (NCT02588833) | Apellis Pharmaceuticals, Inc. | 2015-12-01 |
| Botulinum Toxin to Improve Cosmesis of Primary Cleft Lip Repair (NCT02247193) | The University of Texas Health Science Center, Houston | 2015-12-01 |
| ARIES for Vasculogenic Erectile Dysfunction (NCT02620982) | Dornier MedTech Systems | 2015-12-01 |
| A Study to Assess Safety and Efficacy of Umbilical Cord-derived Mesenchymal Stromal Cells in Knee Osteoarthritis (NCT02580695) | Francisco Espinoza, MD | 2015-12-01 |
| A Study to Investigate the Effect of JNJ-63623872 at Steady-state on the Steady-state Pharmacokinetics of Ethinylestradiol and Norethindrone (NCT02652650) | Janssen Research & Development, LLC | 2015-12-01 |
| Pilot Study to Evaluate the Effects of a Vaccine (HSPPC-96) Combined With Ipilimumab in Patients With Advanced Melanoma (NCT02452281) | Rabih Said | 2015-12-01 |
| Evaluation of TAK-058 and Ondansetron on P50 Auditory Gating in Participants With Stable Schizophrenia (NCT02614586) | Takeda | 2015-12-01 |
| Study to Evaluate Ibrutinib Combination Therapy in Patients With Selected Gastrointestinal and Genitourinary Tumors (NCT02599324) | Pharmacyclics LLC. | 2015-12-01 |
| Alsertib (MLN8237) and Brentuximab Vedotin for Relapsed/Refractory CD30-Positive Lymphomas and Solid Malignancies (NCT02780011) | Eric Bernicker, MD | 2015-12-01 |
| A Study of Oral L-citrulline in Sickle Cell Disease (NCT02659644) | University of Mississippi Medical Center | 2015-12-01 |
| A Comparison Study to Evaluate the Pharmacokinetics and Safety of NK-104-CR in Healthy Adult Volunteers (NCT02634034) | Kowa Research Institute, Inc. | 2015-12-01 |
| A Phase 1/2 Multicenter Dose Escalation and Expansion Study Of NKTR-214 In Subjects With Locally Advanced Or Metastatic Solid Tumors (NCT02869295) | Nektar Therapeutics | 2015-12-01 |
| Validation of Aspiration Markers in Intubated Patients (NCT02598713) | Massachusetts General Hospital | 2015-12-01 |
| Can Oxytocin Enhance the Placebo Effect? (NCT02745522) | University of Electronic Science and Technology of China | 2015-12-01 |
| Ketamine for Relapse Prevention in Recurrent Depressive Disorder (NCT02661061) | St Patrick's Hospital, Ireland | 2015-12-01 |
| Clinical Study of Regeneration on Larynx Soft Tissue Guided by Functional Collagen Scaffold (NCT02754284) | Chinese Academy of Sciences | 2015-12-01 |
| A Pharmacokinetic Study of DE-117 Ophthalmic Solution in Healthy Adult Male Subjects - Phase I Study - (NCT02650063) | Santen Pharmaceutical Co., Ltd. | 2015-12-01 |
| A Study of the Safety and Pharmacokinetics of Levodopa Following Administration of CVT 301 (Levodopa Inhalation Powder) in Adults With Asthma (NCT02633007) | Acorda Therapeutics | 2015-12-01 |
| A Study of LY2599666 in Healthy Participants and Participants With Mild Cognitive Impairment or Alzheimer's Disease (AD) (NCT02614131) | Eli Lilly and Company | 2015-12-01 |
| A Study to Assess The Effects Of Effexor XR On Cardiac Repolarization In Healthy Adult Subjects (NCT02637193) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2015-12-01 |
| Study of Enzalutamide With and Without Sorafenib in Advanced Hepatocellular Carcinoma Patients (NCT02642913) | Memorial Sloan Kettering Cancer Center | 2015-12-01 |
| PK/PD Study of Gan & Lee's Insulin Glargine Injection in Comparison to Lantus in Type 1 Diabetes (NCT02506647) | Gan and Lee Pharmaceuticals, USA | 2015-12-01 |
| Adjuvant Dendritic Cell-immunotherapy Plus Temozolomide in Glioblastoma Patients (NCT02649582) | University Hospital, Antwerp | 2015-12-01 |
| Safety and Pharmacodynamics of SEL-212 (Pegsiticase + SEL-110) in Subjects With Elevated Blood Uric Acid Levels (NCT02648269) | Selecta Biosciences, Inc. | 2015-12-01 |
| Ethanol and Cannabinoid Effects on Simulated Driving and Related Cognition (NCT02404688) | Yale University | 2015-12-01 |
| A Study of the Safety and Tolerability of Intravitreal LKA651 in Patients With Diabetic Macular Edema (NCT02281292) | Alcon Research | 2015-12-01 |
| Enzalutamide With Ribociclib in Treating Patients With Metastatic Castrate-Resistant, Chemotherapy Naive Prostate Cancer That Retains Retinoblastoma Expression (NCT02555189) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2015-12-01 |
| Bioavailability of Red Wine Anthocyanins (NCT02975856) | Universidade do Porto | 2015-12-01 |
| The Drug-drug Interaction of SP2086 and Metformin (NCT02813863) | Jiangsu HengRui Medicine Co., Ltd. | 2015-12-01 |
| Combination Therapy of SyB C-1101 and Azacytidine in Patients With Myelodysplastic Syndrome (NCT02783547) | SymBio Pharmaceuticals | 2015-12-01 |
| Safety and Efficacy of Vitamin C Infusion in Combination With Local mEHT to Treat Non Small Cell Lung Cancer (NCT02655913) | Clifford Hospital, Guangzhou, China | 2015-12-01 |
| A Study of BBI608 Administrated With FOLFIRI + Bevacizumab in Adult Patients With Metastatic Colorectal Cancer (NCT02641873) | Sumitomo Pharma Co., Ltd. | 2015-12-01 |
| Allogeneic Mesenchymal Stromal Cells in Elderly Patients With Hip Fracture (NCT02630836) | Banc de Sang i Teixits | 2015-12-01 |
| A Study of Various Formulations of LY900014 in Healthy Participants (NCT02636361) | Eli Lilly and Company | 2015-12-01 |
| A Study to Evaluate the Safety and Pharmacokinetics of CDX-0158 in Adult Patients With Advanced Solid Tumors (NCT02642016) | Celldex Therapeutics | 2015-12-01 |
| A Phase Ib Study of Belinostat With RDHAP Chemotherapy (Dexamethasone, Cytarabine, Cisplatinum) in Adults With Relapsed or Refractory Diffuse Large B-cell Lymphoma (NCT02532192) | M.D. Anderson Cancer Center | 2015-12-01 |
| Dose Escalation Study of HBI-8000 in Combination With Paclitaxel and Trastuzumab in Women With Advanced or Metastatic HER2+ Breast Cancer (NCT02569489) | HUYABIO International, LLC. | 2015-12-01 |
| Sapanisertib or Pazopanib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Sarcoma (NCT02601209) | National Cancer Institute (NCI) | 2015-11-30 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Preliminary Efficacy of Atezolizumab (Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) in Pediatric and Young Adult Participants With Solid Tumors (NCT02541604) | Hoffmann-La Roche | 2015-11-30 |
| A Study to Assess the Effects of Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of Intranasally Administered Esketamine (NCT02611505) | Janssen Research & Development, LLC | 2015-11-30 |
| Photodynamic Therapy and Vismodegib for Multiple Basal Cell Carcinomas (NCT02639117) | University of Arizona | 2015-11-30 |
| Evaluate Safety and Biological Activity of ATYR1940 in Participants With Limb Girdle Muscular Dystrophy 2B (LGMD2B) and Facioscapulohumeral Muscular Dystrophy (FSHD) (NCT02579239) | aTyr Pharma, Inc. | 2015-11-30 |
| MSC2364447C Phase 1b in Systemic Lupus Erythematosus (NCT02537028) | EMD Serono Research & Development Institute, Inc. | 2015-11-30 |
| Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IONIS ANGPTL3-LRx in Healthy Volunteers With Elevated Triglycerides and Participants With Familial Hypercholesterolemia (NCT02709850) | Ionis Pharmaceuticals, Inc. | 2015-11-30 |
| Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors (NCT02552121) | Seagen Inc. | 2015-11-30 |
| A Study to Investigate Safety, Tolerability, and Pharmacokinetics of DSTA4637S in Healthy Volunteers (NCT02596399) | Genentech, Inc. | 2015-11-29 |
| A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RO7020322 Following Oral Administration in Healthy Participants and Chronic Hepatitis B Patients (NCT02604355) | Hoffmann-La Roche | 2015-11-28 |
| In Vivo Characterization of Inflammation With Ferumoxytol, an Ultrasmall Superparamagnetic Iron Oxide Nanoparticle, on 7 Tesla Magnetic Resonance Imaging (NCT02511028) | National Institute of Neurological Disorders and Stroke (NINDS) | 2015-11-27 |
| Icotinib Hydrochloride Cream in Healthy Adults and Psoriasis Patients (NCT02574091) | Betta Pharmaceuticals Co., Ltd. | 2015-11-26 |
| Effects of Melatonin as a Novel Antioxidant and Free Radicals Scavenger in Neonatal Sepsis (NCT03295162) | Mohamed Hussein Metwally | 2015-11-26 |
| A Phase 1, Randomized, Placebo-Controlled, Ascending Cohort, Dose Escalation Study in Normal Healthy Volunteers (NCT02727283) | GlaxoSmithKline | 2015-11-26 |
| MAD Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PB-119 to Subjects With T2DM (NCT03072407) | PegBio Co., Ltd. | 2015-11-24 |
| Pharmacokinetics Study in Patients With Impaired Renal Function and Subjects With Normal Renal Function (NCT02603497) | Astellas Pharma Inc | 2015-11-24 |
| A Study to Assess the Safety and Tolerability of Single Doses of AZD4076 in Healthy Male Subjects (NCT02612662) | AstraZeneca | 2015-11-24 |
| Pembrolizumab and Combination Chemotherapy in Treating Patients With Previously Untreated Diffuse Large B-cell Lymphoma or Grade 3b Follicular Lymphoma (NCT02541565) | University of Washington | 2015-11-24 |
| Dose-Escalation Study Of Palbociclib + Nab-Paclitaxel In mPDAC (NCT02501902) | Pfizer | 2015-11-23 |
| A Study of Nivolumab in Advanced Non-Small Cell Lung Cancer (NSCLC) (NCT02574078) | Bristol-Myers Squibb | 2015-11-23 |
| Inhalation Flow Rate-study (NCT02563197) | Bayer | 2015-11-23 |
| Phase I-Ib/II Study of MBG453 as Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies (NCT02608268) | Novartis Pharmaceuticals | 2015-11-23 |
| LEE011 (Ribociclib) in Combination With Docetaxel Plus Prednisone in mCRPC (NCT02494921) | Rahul Aggarwal | 2015-11-20 |
| Pharmacokinetics of a Novel Vaginal Delivery System for Testosterone and Dehydroepiandrosterone (DHEA) (NCT03967964) | Laboratorios Andromaco S.A. | 2015-11-20 |
| A Phase 1 Study in Subjects With Relapsed or Refractory Multiple Myeloma (NCT02561962) | Amgen | 2015-11-20 |
| Gene Therapy and Combination Chemotherapy in Treating Patients With AIDS-Related Non-Hodgkin Lymphoma (NCT02337985) | City of Hope Medical Center | 2015-11-20 |